Related Experiment Videos
Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute
1Centre de recherche sur les matériaux d'intérêt biologique UPRES EA 2158, Faculté de Chirurgie Dentaire, Nantes, France.
Biomaterials
|October 30, 1998
Summary
Biphasic calcium phosphate ceramics (BCP) offer controlled resorption and bone substitution for bone grafts. Optimized HA/TCP ratios enhance new bone formation by releasing essential ions.
Area of Science:
- Biomaterials Science
- Orthopedic Surgery
- Bioceramics
Background:
- Calcium phosphate ceramics are crucial for bone grafting, requiring precise control over resorption and substitution.
- The bioactive concept aims to improve integration and healing at the bone-material interface.
Purpose of the Study:
- To explore the development and application of biphasic calcium phosphate ceramics (BCP) for bone grafting.
- To understand the role of HA/TCP ratios in controlling BCP dissolution and bone formation.
- To investigate the bone/material interface dynamics, including cellular response and material transformation.
Main Methods:
- Development of biphasic calcium phosphate ceramics (BCP) with optimized hydroxyapatite (HA) and tricalcium phosphate (TCP) ratios.
- In vitro and in vivo studies to evaluate biomaterial resorption, bone substitution, and cellular interactions.
- Analysis of material transformation to carbonate hydroxyapatite (CHA) at the bone/material interface.
Main Results:
- An optimal HA/TCP balance in BCP was achieved for controlled dissolution and ion release.
- BCP demonstrated effective seeding of new bone formation.
- Cellular responses and biodegradation processes at the bone/material interface were characterized, including CHA formation.
Conclusions:
- Optimized BCP formulations provide controlled resorption and promote bone regeneration.
- The bioactive nature of BCP facilitates dynamic bone-material integration.
- BCP shows promise as a bone graft material in various forms, including bulk, coatings, and injectable bone substitutes (IBS).